Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408277 · ClinicalTrials.gov registry record · Phase 4
Using Santyl on Diabetic Foot Ulcers
A Phase 4 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
NCT01408277 is a Phase 4 study that has completed, run by Healthpoint. The registered enrollment target is 55 participants.
The verdict
NCT01408277, a Phase 4 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
Study Summary
Subjects enrolled in this study will either use Santyl daily or follow standard care procedures for up to 6 weeks for their diabetic foot wound. After 6 weeks of treatment, the subjects will continue into the follow-up phase for an additional 6 weeks. Study doctors will look at the wound in the office each week (up to 12 weeks) to see if the wound is healing. Depending on a number of factors at each office visit, the study doctors may also use a procedure called sharp debridement to remove dead skin from the wound. This study will test the hypothesis that daily treatment of diabetic foot wounds with Santyl will result in more rapid healing, healthier wounds, and fewer required sharp debridements over the study period than for diabetic foot wounds treated in other ways.
Interventions
- PROCEDURE Control
- BIOLOGICAL Santyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01408277
The ClinicalTrials.gov registry entry for NCT01408277 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT01408277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01408277 about?
NCT01408277 is a clinical study titled "Using Santyl on Diabetic Foot Ulcers". Subjects enrolled in this study will either use Santyl daily or follow standard care procedures for up to 6 weeks for their diabetic foot wound. After 6 weeks of treatment, the subjects will continue into the follow-up phase for an additional 6 weeks. Study doctors will look at the wound in the offi...
What is the current status of trial NCT01408277?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2011-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01408277?
The interventions under investigation include: Control (PROCEDURE), Santyl (BIOLOGICAL).
Who is sponsoring clinical trial NCT01408277?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.